Literature DB >> 18356447

Nonalcoholic fatty liver disease.

Chandana G Lall1, Alex M Aisen, Navin Bansal, Kumaresan Sandrasegaran.   

Abstract

OBJECTIVE: The inflammatory subtype of nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, is becoming one of the most important causes of chronic liver disease. In this article, we discuss the epidemiology, pathogenesis, and clinical and radiologic diagnosis of the subtypes of nonalcoholic fatty liver disease.
CONCLUSION: We discuss the current and evolving imaging tests in the evaluation of hepatic fatty content, inflammation, and fibrosis.

Entities:  

Mesh:

Year:  2008        PMID: 18356447     DOI: 10.2214/AJR.07.2052

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  16 in total

1.  Sonographic assessment of fatty liver: intraobserver and interobserver variability.

Authors:  Mustafa Cengiz; Senem Sentürk; Bulent Cetin; Aylin Hasanefendioğlu Bayrak; Senem Uysal Bilek
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 2.  Non-alcoholic fatty liver disease: The diagnosis and management.

Authors:  Shehab M Abd El-Kader; Eman M Salah El-Den Ashmawy
Journal:  World J Hepatol       Date:  2015-04-28

3.  A maternal "junk food" diet in pregnancy and lactation promotes nonalcoholic Fatty liver disease in rat offspring.

Authors:  Stéphanie A Bayol; Bigboy H Simbi; Robert C Fowkes; Neil C Stickland
Journal:  Endocrinology       Date:  2010-03-05       Impact factor: 4.736

Review 4.  Inflammation and Metabolic Complications in HIV.

Authors:  Kassem Bourgi; Celestine Wanjalla; John R Koethe
Journal:  Curr HIV/AIDS Rep       Date:  2018-10       Impact factor: 5.071

5.  Experimental Nonalcoholic Steatohepatitis Induced by Neonatal Streptozotocin Injection and a High-Fat Diet in Rats.

Authors:  Huai-Che Hsu; Masaharu Dozen; Naoto Matsuno; Hiromichi Obara; Ryou Tanaka; Shin Enosawa
Journal:  Cell Med       Date:  2013-10-23

6.  Breath-hold 1H-magnetic resonance spectroscopy for intrahepatic lipid quantification at 3 Tesla.

Authors:  Miriam A Bredella; Reza Hosseini Ghomi; Bijoy J Thomas; Hugue A Ouellette; Dushyant V Sahani; Karen K Miller; Martin Torriani
Journal:  J Comput Assist Tomogr       Date:  2010 May-Jun       Impact factor: 1.826

7.  Contrast-enhanced computed tomography for the diagnosis of fatty liver: prospective study with same-day biopsy used as the reference standard.

Authors:  Dae Yoon Kim; Seong Ho Park; Seung Soo Lee; Hye Jin Kim; So Yeon Kim; Min-Young Kim; Yedaun Lee; Tae Kyoung Kim; Korosh Khalili; Mi Hyun Bae; Joo Yeon Lee; Sung-Gyu Lee; Eun Sil Yu
Journal:  Eur Radiol       Date:  2009-09-02       Impact factor: 5.315

8.  The prevalence of metabolic risk factors among outpatients with diagnosed nonalcoholic fatty liver disease in Lithuania.

Authors:  Jonas Valantinas; Daiva Asta Apanaviciene; Ligita Maroziene; Audrius Sveikata
Journal:  Med Sci Monit       Date:  2012-05

9.  MR imaging in liver cirrhosis: classical and new approaches.

Authors:  Luis Martí-Bonmatí; Fructuoso Delgado
Journal:  Insights Imaging       Date:  2010-08-05

10.  Role of Magnetic Resonance Imaging in the Monitoring of Patients with Nonalcoholic Fatty Liver Disease: Comparison with Ultrasonography, Lipid Profile, and Body Mass Index.

Authors:  Nikhil Makhija; Naval K Vikram; Gurdeep Kaur; Raju Sharma; Deep N Srivastava; Kumble S Madhusudhan
Journal:  J Clin Exp Hepatol       Date:  2019-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.